Skip to content

Nasdaq · CIK 0001069530

FLNA CASSAVA SCIENCES INC

Insider trading from SEC Form 4. Last filing 11 d ago. Close $0.82 on Oct 9, 2026, +21% from the 52-week low and -82% from the high.

Last 90 days

Net insider value
+$356k
more bought than sold
Buys
2
$356k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company

Price and insider trades, last year

FLNAOct 9, 2026 · close 0.82

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at CASSAVA SCIENCES INC, scored.

ScoreInsiderValueHoldingsPrice contextFiled
58ModerateRichard Barry
President & CEO
buy
$278k
306,813 shares
+30%+35% from low-80% from high
45ModerateRichard Barry
President & CEO
buy
$78k
93,091 shares
+10%+25% from low-82% from high
39WeakRobert Eugene Anderson Jr
director
buy
$25k
8,600 shares
-+144% from low-38% from high
65NotableRichard Barry
President & CEO
buy
$414k
150,000 shares
+19%+121% from low-92% from high
61NotableRichard Barry
President & CEO
buy
$202k
73,385 shares
+10%+131% from low-91% from high
50ModerateRobert Christopher Cook
Chief Operating & Legal Office
buy
$40k
13,725 shares
-+145% from low-91% from high
46ModerateRichard Barry
President & CEO
buy
$16k
7,172 shares
+1%+95% from low-93% from high
69NotableRichard Barry
President & CEO
buy
$535k
237,941 shares
+51%+92% from low-93% from high
48ModerateEric Schoen
Chief Financial Officer
sell
$238k
61,800 shares
-3090%-
43ModerateJames William Kupiec
Chief Medical Officer
sell
$15k
4,000 shares
-100%-

Transactions

The last 30 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+206,813$0.90$186k1,237,96411 d ago
Sep 30, 2026Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+100,000$0.92$92k1,337,96411 d ago
Sep 28, 2026Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+93,091$0.84$78k1,031,15112 d ago
Nov 24, 2025Robert Eugene Anderson Jr
director
POpen-market purchase
Common Stock
+8,600$2.90$25k8,600Nov 25, 2025
Nov 20, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+150,000$2.76$414k938,060Nov 24, 2025
Nov 19, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+73,385$2.75$202k788,060Nov 20, 2025
Oct 21, 2025Dawn Carter Bir
director
AGrant or award
Stock Option (Right to Buy)derivative
+53,000$0.00$053,000Oct 22, 2025
Sep 30, 2025Robert Christopher Cook
Chief Operating & Legal Office
POpen-market purchase
Common Stock
+13,725$2.91$40k13,725Oct 2, 2025
Sep 22, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+7,172$2.28$16k714,675Sep 23, 2025
Sep 18, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+5,400$2.13$12k474,962Sep 22, 2025
Sep 18, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+185,233$2.24$415k660,195Sep 22, 2025
Sep 19, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+400$2.25$900660,595Sep 22, 2025
Sep 19, 2025Richard Barry
President & CEO
POpen-market purchase
Common Stockindirect: By Trust
+46,908$2.29$107k707,503Sep 22, 2025
May 23, 2025Patrick J Scannon Md Phd
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,500$0.00$026,500Jul 16, 2025
May 23, 2025Claude Nicaise
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,500$0.00$026,500May 27, 2025
May 23, 2025Pierre Gravier
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,500$0.00$026,500May 27, 2025
May 23, 2025Robert Z Gussin
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,500$0.00$026,500May 27, 2025
May 23, 2025Donnell Michael J O
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,500$0.00$026,500May 27, 2025
May 23, 2025Robert Eugene Anderson Jr
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,500$0.00$026,500May 27, 2025
Apr 17, 2025Richard Barry
President & CEO
AGrant or award
Stock Option (Right to Buy)derivative
+350,000$0.00$0350,000Apr 21, 2025
Apr 17, 2025Robert Christopher Cook
Chief Operating & Legal Office
AGrant or award
Stock Option (Right to Buy)derivative
+100,000$0.00$0100,000Apr 21, 2025
Apr 17, 2025Freda Nassif
Chief Business Officer
AGrant or award
Stock Option (Right to Buy)derivative
+100,000$0.00$0100,000Apr 21, 2025
Apr 17, 2025Eric Schoen
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+100,000$0.00$0100,000Apr 21, 2025
Nov 29, 2024Eric Schoen
Chief Financial Officer
MOption exercise
Common Stock
+50,000$1.18$59k71,300Dec 3, 2024
Nov 29, 2024James William Kupiec
Chief Medical Officer
SOpen-market sale
Common Stock
-4,000$3.87$15k0Dec 3, 2024
Nov 29, 2024Eric Schoen
Chief Financial Officer
SOpen-market sale
Common Stockindirect: By limited liability corporation
-2,000$3.82$7,6400Dec 3, 2024
Nov 29, 2024Eric Schoen
Chief Financial Officer
SOpen-market sale
Common Stock
-59,800$3.86$231k11,500Dec 3, 2024
Nov 29, 2024Eric Schoen
Chief Financial Officer
MOption exercise
Stock Option (Right to Buy)derivative
-50,000$0.00$00Dec 3, 2024
Nov 18, 2024Freda Nassif
Chief Commercial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+100,000$0.00$0100,000Nov 20, 2024
Nov 18, 2024Jaren Landen
Chief Clinical Dev. Officer
AGrant or award
Stock Option (Right to Buy)derivative
+85,000$0.00$085,000Nov 20, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

FLNA insider trading: CASSAVA SCIENCES INC | InsiderTell